ciprofloxacin has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 16 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 9.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| "The purpose of this study was to identify risk factors and improve preventive strategies for febrile neutropenia (FEN) in children with leukemia who were receiving ciprofloxacin prophylaxis." | 8.31 | Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis ( Alıcı, N; Kaya, Z; Kırkız, S; Koçak, Ü, 2023) |
| "To report the first case of ciprofloxacin-associated hemolytic-uremic syndrome (HUS)." | 7.71 | Ciprofloxacin-associated hemolytic-uremic syndrome. ( Allan, DS; Barr, RM; Chin-Yee, IH; Clark, WF; Thompson, CM, 2002) |
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 5.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| "Compared to historical controls, patients in this study receiving prophylactic ciprofloxacin had a reduced rate and duration of hospitalization and incidence of Gram-negative bacteremia." | 5.11 | A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia. ( Abbas, AA; Chedid, FD; Felimban, SK; Fryer, CJ; Khattab, TM; Yousef, AA, 2004) |
| "The purpose of this study was to identify risk factors and improve preventive strategies for febrile neutropenia (FEN) in children with leukemia who were receiving ciprofloxacin prophylaxis." | 4.31 | Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis ( Alıcı, N; Kaya, Z; Kırkız, S; Koçak, Ü, 2023) |
| "To report the first case of ciprofloxacin-associated hemolytic-uremic syndrome (HUS)." | 3.71 | Ciprofloxacin-associated hemolytic-uremic syndrome. ( Allan, DS; Barr, RM; Chin-Yee, IH; Clark, WF; Thompson, CM, 2002) |
| "Ciprofloxacin AUC24 was 16." | 1.56 | Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients. ( Bierings, MB; de Haas, V; Kaspers, GJL; Mathôt, RAA; Pieters, R; Sassen, SDT; Te Loo, DMWW; Tissing, WJE; van den Bos, C; van der Sluis, IM; van Westreenen, M; Zwaan, CM, 2020) |
| "Ciprofloxacin therapy was initiated and renal function was restored within 2 days." | 1.33 | Pseudomonas aeruginosa infection: an uncommon cause of post-renal obstruction following induction therapy for acute lymphoblastic leukemia. ( Burghardt, KM; Feber, J; Filler, G; Halton, J; Leonard, M, 2006) |
| "In ciprofloxacin-treated patients the flora were almost completely ciprofloxacin-resistant, whereas in the control groups resistant flora were detected only occasionally." | 1.28 | Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. ( Huovinen, P; Kotilainen, P; Nikoskelainen, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kaya, Z | 1 |
| Alıcı, N | 1 |
| Kırkız, S | 1 |
| Koçak, Ü | 1 |
| Sassen, SDT | 1 |
| Mathôt, RAA | 1 |
| Pieters, R | 1 |
| de Haas, V | 1 |
| Kaspers, GJL | 1 |
| van den Bos, C | 1 |
| Tissing, WJE | 1 |
| Te Loo, DMWW | 1 |
| Bierings, MB | 1 |
| van Westreenen, M | 1 |
| van der Sluis, IM | 1 |
| Zwaan, CM | 1 |
| Castagnola, E | 1 |
| Moroni, C | 1 |
| Bandettini, R | 1 |
| Caprino, D | 1 |
| Haupt, R | 1 |
| Fatima, A | 1 |
| Afridi, FI | 1 |
| Qureshi, A | 1 |
| Farooqi, BJ | 1 |
| Hussain, A | 1 |
| Yeh, TC | 1 |
| Liu, HC | 1 |
| Hou, JY | 1 |
| Chen, KH | 1 |
| Huang, TH | 1 |
| Chang, CY | 1 |
| Liang, DC | 1 |
| Laoprasopwattana, K | 1 |
| Khwanna, T | 1 |
| Suwankeeree, P | 1 |
| Sujjanunt, T | 1 |
| Tunyapanit, W | 1 |
| Chelae, S | 1 |
| Yousef, AA | 1 |
| Fryer, CJ | 1 |
| Chedid, FD | 1 |
| Abbas, AA | 1 |
| Felimban, SK | 1 |
| Khattab, TM | 1 |
| Burghardt, KM | 1 |
| Leonard, M | 1 |
| Feber, J | 1 |
| Halton, J | 1 |
| Filler, G | 1 |
| Rosolen, A | 1 |
| Drigo, P | 1 |
| Zanesco, L | 1 |
| Horowitz, HW | 1 |
| Holmgren, D | 1 |
| Seiter, K | 1 |
| Carlens, S | 1 |
| Ringdén, O | 1 |
| Aschan, J | 1 |
| Hägglund, H | 1 |
| Ljungman, P | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Allan, DS | 1 |
| Thompson, CM | 1 |
| Barr, RM | 1 |
| Clark, WF | 1 |
| Chin-Yee, IH | 1 |
| Donnelly, JP | 2 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| Arning, M | 1 |
| Wolf, HH | 1 |
| Aul, C | 1 |
| Heyll, A | 1 |
| Scharf, RE | 1 |
| Scheider, W | 1 |
| Kotilainen, P | 1 |
| Nikoskelainen, J | 1 |
| Huovinen, P | 1 |
| Weers-Pothoff, G | 1 |
| Novakova, IR | 1 |
| Muytjens, HL | 1 |
5 trials available for ciprofloxacin and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agen | 2013 |
A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia.
Topics: Adolescent; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Child; Child, Preschool; Cipr | 2004 |
Stepdown single agent antibiotic therapy for the management of the high risk neutropenic adult with hematologic malignancies.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciproflo | 1996 |
Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Colistin; Drug Therap | 1992 |
Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
Topics: Bacterial Infections; Ciprofloxacin; Colistin; Humans; Neutropenia; Ofloxacin; Precursor Cell Lympho | 1990 |
11 other studies available for ciprofloxacin and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis
Topics: Child; Ciprofloxacin; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphobl | 2023 |
Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients.
Topics: Anti-Bacterial Agents; Area Under Curve; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; M | 2020 |
Ciprofloxacin prophylaxis in children with acute leukemia in an era of increasing antibiotic resistance.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Female; Fever; Humans; Male; Neutropeni | 2013 |
Bacteremia due to Aeromonas hydrophila in acute lymphoblastic leukemia.
Topics: Acute Disease; Aeromonas hydrophila; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Fever | 2013 |
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschoo | 2014 |
Pseudomonas aeruginosa infection: an uncommon cause of post-renal obstruction following induction therapy for acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anuria; Ciprofloxacin; Humans; Hypertension; Infant; | 2006 |
Acute hemiparesis associated with ciprofloxacin.
Topics: Acute Disease; Adolescent; Ciprofloxacin; Cranial Nerve Diseases; Female; Hemiplegia; Humans; Precur | 1994 |
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Cyclophosphamide; Disease- | 1998 |
Ciprofloxacin-associated hemolytic-uremic syndrome.
Topics: Anti-Infective Agents; Ciprofloxacin; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Precurso | 2002 |
Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.
Topics: Aged; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Female; Humans; Immune Tolerance; Leukem | 1990 |
Bacteraemia caused by Stomatococcus mucilaginosus in a granulocytopenic patient with acute lymphocytic leukaemia.
Topics: Adult; Agranulocytosis; Amsacrine; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Proto | 1989 |